2022 News Briefs - International Neuromodulation Society

Earlier News:

Company Announces Expanded Labeling for Spinal Cord Stimulation System

Jan. 19, 2022 - Nevro Corp. announced FDA approval for expanded labeling for its 10 kHz spinal cord stimulation system for treatment of non-surgical refractory back pain. Separately, Nevro also announced data presented in 17 clinical abstracts at the North American Neuromodulation Society annual meeting, including clinical trial data at 12 and 18 months, concerning use of 10 kHz spinal cord stimulation in patients with chronic pain.(Source: PR Newswire)

Company Announces Breakthrough Device Designation Pertaining to Treatment of Peripheral Neuropathy

Jan. 18, 2022 - NeuroMetrix, Inc. announced its Quell noninvasive neurostimulator has received U.S. FDA Breakthrough Device designation for the treatment of chemotherapy-induced peripheral neuropathy. (Source: Globe Newswire)

Army, Air Force Evince Interest in Noninvasive Neurostimulation

Jan. 17, 2022 - A video report of nearly 5 minutes details how the U.S. Army and Air Force are trying noninvasive vagus nerve stimulation or noninvasive brain stimulation as a potential way to improve alertness and focus during training, as well as for its potential to treat post-traumatic stress disorder. (Source: Army Times)

$9.8 Million Competition Announced for Nerve Stimulation for Autonomic Function

Jan. 18, 2022 - The U.S. National Institutes of Health (NIH) announced it has launched the first phase of its $9.8 million Neuromod Prize that seeks to accelerate peripheral nerve stimulation to "independently regulate two or more desired autonomic functions without unintended effects on non-target organs". The prize was initiated under the NIS Common Fund's Stimulating Peripheral Activity to Relieve Conditions (SPARC)  (Source: National Institutes of Health)

Study Will Evaluate Simultaneous Implant of Spinal Fusion and Neuromodulation Devices in Chronic Low Back Pain Patients

Jan. 13, 2022 - Syner Fuse, Inc. announced the first implantation in a proof-of-concept study of spinal fusion hardware and a dorsal root ganglion neurostimulator simultaneously in an individual suffering from chronic low back pain. (Source: PR Newswire)

Three-Month Data Presented Concerning Low-Energy Spinal Cord Stimulation

Jan. 13, 2022 - Three-month data were presented from a clinical trial of differential target multiplexed spinal cord stimulation endurance therapy. (Source: Spinal News International)

Adaptive Spinal Cord Stimulation System Receives Breakthrough Device Designation

Jan. 13, 2022 - Wavegate Corporation announced the FDA has granted Breakthrough Device designation for its optical reflectometry system for closed-loop adaptive modulation of spinal cord stimulation. (Source: KPVI)

Startup Closes $10 Million Funding Round

Jan. 11, 2022 - GrayMatters Health announced closure of a $10 million Series A funding round, and plans to apply the funds towards further commercial development of its device for digital self-neuromodulation therapy to support emotional regulation. (Source: Cision)

Noninvasive Neurostimulation Methods Investigated for Long COVID

Jan. 5, 2022 - A news feature discusses recent lines of research into noninvasive neurostimulation as a potential treatment for long COVID. (Source: IEEE Spectrum)

PTSD Treatment Receives Breakthrough Device Designation

Jan. 12, 2022 - The company electroCore, Inc. announced its noninvasive vagus nerve stimulation system received Breakthrough Device designation from the FDA for treatment of post-traumatic stress disorder. (Source: Globe Newswire)

Article Surveys the State of Therapeutic Brain Stimulation Development

Jan. 12, 2022 - A news feature describes research into deep brain stimulation or transcranial magnetic stimulation to potentially treat psychiatric or other conditions. (Source: STAT)

Closed-Loop Spinal Cord Stimulation Two-Year Outcomes Reported

Jan. 8, 2022 - In a secondary analysis, a team of co-authors published two-year outcomes in a randomized controlled trial of closed-loop spinal cord stimulation for chronic back and leg pain. (Source: JAMA Neurology)

Team Unveils a Wearable Noninvasive Brain Stimulation Device

Jan. 7, 2022 - A wearable device its inventors say delivers pulsed magnetic stimulation made a debut at the Consumer Electronics Show, and is being presented as being designed for creation of a meditative state. (Source: Medscape)

Transcranial Direct Current Stimulation Studied in Long COVID

Jan. 7, 2022 - A news feature that references past or future studies discusses neurostimulation as a potential therapy for long COVID. (Source: IFL Science!)

Two-Year Results Published in Clinical Trial of Neurostimulation for Chronic Pain

Jan. 3, 2022 - An article in press presents two-year results in a randomized controlled trial of restorative neurostimulation in patients with chronic disabling back pain secondary to multifidus muscle dysfunction. (Source: Neuromodulation: Technology at the Neural Interface)

Guidelines Published on Spinal Cord Stimulation Surgical Technique

Jan. 1, 2022 - The International Neuromodulation Society’s Neurostimulation Appropriateness Consensus Committee has published recommendations for surgical technique -- including preoperative assessment and postoperative management -- for spinal cord stimulation for the treatment of chronic pain. (Source: Neuromodulation: Technology at the Neural Interface)

International Guidance Published on Cervical Neurostimulation

Jan. 1, 2022 - A multispecialty group of physicians convened by the International Neuromodulation Society, through the  International Neuromodulation Society’s  Neurostimulation Appropriateness Consensus Committee, has published evidence-based guidance on the use of cervical neuromodulation. (Source: Neuromodulation: Technology at the Neural Interface)

Company Announces Expanded MRI Compatibility Approval

Jan. 4, 2022 - Abbott announced that the FDA has approved expanded MRI compatibility labeling of its XR spinal cord stimulation system with Octrode leads. (Source: Mass Device)